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Key Clinical Message
In the context of leukocytosis due to increased number of neutrophils and their
precursors, with significant dysgranulopoiesis and no or minimal basophilia
and no or minimal monocytosis, the typical feature of “clumped” chromatin,
in irregularly coarse compacted nuclei, should lead to suspect the diagnosis of
atypical chronic myeloid leukemia.
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A 68-year-old female patient presented to our emergency
department with progressive fatigue, dyspnea, and gener-
alized bone pain. Medical examination revealed fever,
diffuse bruising, and hematomas. Total thyroidectomy
due to unspecified cancer, poorly controlled essential
hypertension and neurological hearing impairment were
relevant issues in medical history. The complete blood
count revealed hyperleukocytosis (WBC 319 9 109/L),
severe normocytic anemia (Hb 5.6 g/dL, MCV 98 fl),
thrombocytopenia (20 9 109/L), highly increased LDH
(3241 U/L; n.v. 230–460), and normal chemistry and
coagulation tests. The peripheral blood smear, shown
in Figure 1, depicted a differential count (%) of neu-
trophils 62, eosinophils 0, basophils 0, lymphocytes 3,
monocytes <1, promyelocytes 1, myelocytes 5, metamye-
locytes 13, blasts 16. Moreover, an intense dysgranu-
lopoiesis characterized by the distinctive feature of
“clumped” chromatin, in irregularly coarse compacted
nuclei, was also noticed (detail in Fig. 2). Leukocyte alka-
line phosphatase score was markedly reduced. These char-
acteristics were highly suspicious for atypical chronic
myeloid leukemia (aCML). According to 2016 WHO [1],
this condition is classified as a myeloproliferative/
myelodysplastic syndrome characterized by (1) leukocyto-
sis due to increased number of neutrophils and their
precursors, with significant dysgranulopoiesis, which may
include abnormal chromatin clumping, with no or mini-
mal absolute basophilia and no or minimal absolute
monocytosis; (2) no evidence of BCRABL1 fusion gene,
PDGFRA, PDGFRB, FGFR1 rearrangement, or PCM1JAK2
translocation, and (3) a hypercellular bone marrow with
granulocytic proliferation and granulocytic dysplasia,
without blasts exceeding 20% in either bone marrow
(BM) or peripheral blood. BM aspiration and trephine
biopsy were performed, showing (Fig. 3) a nearly 100%
cellularity with markedly reduced erythropoiesis and
megakaryocytopoiesis, along with a hyperplastic and dys-
plastic granulocytic lineage; blast cells were accounted
between 10% and 20% on BM smears. Results of stan-
dard cytogenetic and molecular analysis revealed a normal
karyotype, and the absence of the above-mentioned
rearrangements mandatory for diagnosing aCML.
Interestingly, within the standard common myeloid
mutations panel, the only molecular marker we found
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was FLT3 ITD. The patient was treated with three
subsequent leukapheretic procedures in association with
hydroxycarbamide, obtaining reduction in leukocytosis to
values near to 30 9 109/L. Nonetheless, clinical condi-
tions rapidly worsened: the patient developed progressive
confusion and generalized weakness. Head CT detected
multiple intra-parenchimal hemorrhagic lesions not suit-
able for surgical intervention. Moreover, diabetes mellitus
was diagnosed and acute renal failure developed during
hospital admission. Considering patient’s significant
comorbidities, she was discharged after clinical stabiliza-
tion and continued supportive therapy only.
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Figure 1. Peripheral blood smear, May-Gr€unwald Giemsa stain, 600x.
In detail: medium-sized myeloblasts, promonocytes, and atypical
neutrophils with a characteristic “clumped” chromatin, in irregularly
compacted nuclei, and hypergranular cytoplasm can be noticed.
Figure 2. Peripheral blood smear, May-Gr€unwald Giemsa stain,
1000x. Detail of atypical neutrophils with a characteristic “clumped”
chromatin, in irregularly compacted nuclei, and hypergranular
cytoplasm.
Figure 3. Bone marrow trephine biopsy, hematoxylin and eosin stain,
200x. In detail: an extremely hypercellular bone marrow, with intense
granulocytic hyperplasia showing dysplastic maturation, can be seen.
916 ª 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Atypical chronic myeloid leukemia: the hallmark morphologic features of peripheral blood smear A. Gilioli et al.
